Bioequivalence Study of Revolade® Eltrombopag 50 mg (NCT06834451)

🧪 Interventions in This Study

• Revolade® (DRUG)
• Eltrombopag (EPAG) (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Centro de Atención e Investigación Médica — Chía, Cundinamarca

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Healthy

• Xanthohumol Metabolism and Signature — Portland, Oregon
• Examining the Effects of Regular Brief Internet-based Meditation Practice on Mental Health and Well Being — Stanford, California
• A Provider Intervention to Reduce Financial Toxicity in Patients With Cancer Through Improved Treatment Cost Discussions — Detroit, Michigan
• A Trial to Evaluate Tolerability and Immunogenicity of V540D in Healthy Adults (V540D-004) — Hollywood, Florida
• Pediatric Parenting Support in Flint — Flint, Michigan
• Biomarker-estimated Flavanol Intake in Davis (FID) — Davis, California

Explore by condition: All Healthy clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.